ID   BJAB-HR1K-A5
AC   CVCL_E4B1
SY   BJAB-HR1K clone A5; A5
RX   PubMed=191406;
RX   PubMed=196397;
CC   Population: African; Kenyan.
CC   Virology: EBV-negative cell line infected with EBV from P3HR-1 cell line (Cellosaurus=CVCL_2676) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.His193Arg (c.578A>G); ClinVar=VCV000184979; Zygosity=Unspecified (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Groin; UBERON=UBERON_0008337.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C2912; Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B6UK ! BJAB-HR1K
SX   Female
AG   5Y
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
RX   PubMed=191406; DOI=10.1002/ijc.2910190306;
RA   Fresen K.-O., Merkt B., Bornkamm G.-W., zur Hausen H.;
RT   "Heterogeneity of Epstein-Barr virus originating from P3HR-1 cells. I.
RT   Studies on EBNA induction.";
RL   Int. J. Cancer 19:317-323(1977).
//
RX   PubMed=196397; DOI=10.1016/0042-6822(77)90065-4;
RA   zur Hausen H., Fresen K.-O.;
RT   "Heterogeneity of Epstein-Barr virus. II. Induction of early antigens
RT   (EA) by complementation.";
RL   Virology 81:138-143(1977).
//